Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia

By Faries Douglas E.   Ascher-Svanum Haya   Nyhuis Allen W.   Kinon Bruce J.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1399-1405

Informa Healthcare

Access to resources Recommend Favorite

Bone density after teriparatide in patients with or without prior antiresorptive treatment: one-year results from the EUROFORS study*

By Minne Helmut   Audran Maurice   Simõões Maria E.   Obermayer-Pietsch Barbara   Sigurððsson Gunnar   Maríín Fernando   Dalsky Gail P.   Nickelsen Thomas    

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3117-3128

Informa Healthcare

Access to resources Recommend Favorite

Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12‐month multicentre observational prospective cohort study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 356-363

John Wiley & Sons Inc

Access to resources Recommend Favorite

An observational study of two rehabilitation strategies for patients with chronic pain, focusing on sick leave at one-year follow-up

By Merrick Daniel   Sundelin Gunnevi   Stålnacke Britt-Marie  

Journal of Rehabilitation Medicine, Vol. 45, Iss. 10, 2013-11 ,pp. : 1049-1057

Medical Journals Limited

Access to resources Recommend Favorite

One-Year Outcome and Its Prediction in First-Episode Schizophrenia – A Naturalistic Study

By  

Psychopathology, Vol. 41, Iss. 2, 2007-12 ,pp. : 115-123

Karger

Access to resources Recommend Favorite